+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Human herpesvirus-6 viremia is an independent predictor of invasive fungal infections in liver transplant recipients



Human herpesvirus-6 viremia is an independent predictor of invasive fungal infections in liver transplant recipients



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 441




(PDF emailed within 1 workday: $29.90)

Accession: 035053116

Download citation: RISBibTeXText


Related references

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 69(12): 2566-2573, 2000

Invasive fungal infections in liver transplant recipients. Experimental and Clinical Transplantation 12 Suppl 1: 110-116, 2014

Invasive fungal infections in liver transplant recipients: analysis of 21 cases. Medicina Clinica 110(11): 406-410, 1998

Risk factors for invasive fungal infections in liver transplant recipients. Chinese Medical Journal 125(2): 400, 2012

The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplantation Proceedings 22(1): 242-244, 1990

Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplantation Proceedings 37(5): 2124-2126, 2005

Liposomal Amphotericin B Prevents Invasive Fungal Infections In Liver Transplant Recipients. Transplantation 59(1): 45-50, 1995

Risk factors for early invasive fungal infections in paediatric liver transplant recipients. Mycoses 2018, 2018

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 87(3): 424-435, 2009

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. American Journal of Medicine 103(2): 106-113, 1997

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 73(1): 63-67, 2002

Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clinical Infectious Diseases 24(2): 179-184, 1997

Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 315, 2002

Impact of human herpesvirus-6 viremia on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 286, 2001

Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transplantation 13(7): 1011-1016, 2007